Caliper Life Sciences IncNASDAQ
CALP is defunct.
  • Sep. 8, 2011, 7:12 AM

    PerkinElmer (PKI) agrees to buy Caliper Life Sciences (CALP) for $10.50 a share, a 42% premium over yesterday's closing price. The $600M deal adds "innovative molecular imaging and detection technologies" to PerkinElmer's portfolio, according to its CEO. Shares of CALP +40% premarket.

    | Sep. 8, 2011, 7:12 AM